Johnson & Johnson Innovation
-
Neurology startup Magnolia Neurosciences raises $31M in Series A round
Company seeks to block components of reactivated programmed cell death process implicated in Alzheimer’s disease.
-
In a busy field, biotech incubators are evolving
Life science incubators and accelerators are expanding and broadening their value-adds, as highlighted on Thursday by two significant announcements; one from Boston, one from Israel.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
-
What does J&J’s restructuring, job cuts demonstrate about the status of medical device market growth?
The market for medical devices is still growing, but has gone way down in the past decade. Johnson & Johnson’s restructuring plan appears to be a direct reflection of the numbers.
-
Meet the Mt. Rushmore of healthcare corporate venture capital
Throughout the year Lake Whillans, with the help of MedCity News, has explored two key […]
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
